ARTICLE | Clinical News
Micellular paclitaxel regulatory update
February 15, 2016 8:00 AM UTC
Oasmia submitted an MAA to EMA for Apealea/Paclical micellular paclitaxel to treat epithelial ovarian cancer in combination with carboplatin. Paclical is marketed in Russia (see BioCentury, May 4, 201...